Company Filing History:
Years Active: 1995-2007
Title: The Innovative Contributions of Karin Schmidt-Gollwitzer
Introduction
Karin Schmidt-Gollwitzer is a prominent inventor based in Berlin, Germany. She has made significant contributions to the field of contraception through her innovative research and development. With a total of 9 patents to her name, her work has the potential to impact women's health positively.
Latest Patents
One of her latest patents focuses on a contraception method using competitive progesterone antagonists and novel compounds. This method involves competitive progesterone antagonists, including two novel steroids: 11β,19-[4-(cyanophenyl)-o-phenylene]-17β-hydroxy-17α-(3-hydroxyprop-1(Z)-enyl)-4-androsten-3-one and 11β,19-[4-(3-pyridinyl)-o-phenylene]-17β-hydroxy-17α-(3-hydroxyprop-1(Z)-enyl)-4-androsten-3-one. These compounds inhibit the formation of endometrial glands at doses below those that would inhibit ovulation or cause abortion. This innovative approach aims to achieve oral contraception in females without adversely affecting the menstrual cycle or posing risks to previously implanted fertilized eggs or fetuses.
Career Highlights
Karin Schmidt-Gollwitzer has built her career at Schering Aktiengesellschaft, a company known for its focus on pharmaceuticals and healthcare. Her work has been instrumental in advancing contraceptive methods, showcasing her dedication to improving women's reproductive health.
Collaborations
Throughout her career, she has collaborated with notable colleagues, including Walter Elger and Eckhard Ottow. These partnerships have contributed to her success and the development of her innovative patents.
Conclusion
Karin Schmidt-Gollwitzer's contributions to the field of contraception through her innovative patents highlight her role as a leading inventor in women's health. Her work continues to pave the way for safer and more effective contraceptive methods.